| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $90,270 | +4,500 | +9.7% | $20.06* | 50,750 | 14 Jan 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $608,581 | -4,500 | -8.9% | $135.24 | 46,250 | 14 Jan 2022 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -4,500 | -26% | $0.000000 | 13,000 | 14 Jan 2022 | Common Stock | 4,500 | $20.06 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Options were fully vested on 5/17/13. |